Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Reexamination Certificate
2003-03-20
2009-06-09
Belyavskyi, Michail A (Department: 1644)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
C424S185100
Reexamination Certificate
active
07544359
ABSTRACT:
An effective remedy for ischemic disease, which contains human granulocyte colony-stimulating factor (human G-CSF) and hepatocyte growth factor (HGF) as active ingredients, is disclosed. By administering this remedy, an effective therapy particularly for obstructive arteriosclerosis is provided which can eliminate drawbacks with conventional therapies such as kinesitherapy, pharmacotherapy, revascularization and recently proposed therapies such as gene therapy and intramuscular inoculation of bone marrow cells. Furthermore, the remedy of the present invention can become a remedy for ischemic disease such as ischemic cerebrovascular disorder or ischemic heart disease.
REFERENCES:
patent: 6887477 (2005-05-01), Nagano et al.
patent: 2004/0009940 (2004-01-01), Coleman et al.
patent: 2004/0131585 (2004-07-01), Itescu
patent: 2005/0048026 (2005-03-01), Miyai et al.
patent: 100 33 219 (2002-01-01), None
patent: 0 357 240 (1990-03-01), None
patent: WO 99/17798 (1999-04-01), None
patent: WO 99/17798 (1999-04-01), None
patent: WO 99/45775 (1999-09-01), None
patent: WO 99/45775 (1999-09-01), None
patent: WO 01/94420 (2001-12-01), None
Feldman et al Transplant. Proc. 1998, 30, 4126-4127.
Mestas et al ., J. of Immunology, 2004, 172, pp. 2731-238.
Teuveson et al., Immun. Review 1993, N136, pp. 101-107.
Van Noort et al. International Review of Cytology, 1998, v.178, pp. 127-204.
Orlic et al, “Mobilized bone marrow cells repair the infarcted heart, improving function and survival”, Proc. Natl. Acad. Sci. col. 98, No. 18, pp. 10344-10349. Aug. 2001.
Theocharis et al, “Effect of Granulocyte Colony-Stimulating-Factor Administration on Tissue Regeneration Due to Thioacetamide-Induced Liver Injury in Rats”, Digestive Diseases and Sciences, vol. 44, No. 10, pp. 1990-1996. Oct. 1999.
Theocharis et al, “Effect of two forms of granulocyte-colony-stimulating factor on hepatic regeneration after 70% partial hepatectomy in rats”, Clinical Science, vol. 92, pp. 315-320. 1997.
Orlic, et al, “Bone marrow cells regenerate infarcted myocardium”, Nature, vol. 410, pp. 701-705. Apr. 2001.
Penn et al, “Autologous cell transplantation for the treatment of damaged myocardium”, Progress in Cardiovascular Diseases, vol. 45, No. 1, pp. 21-32. Jul./Aug. 2002.
Jackson, et al, “Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells”, Journal of Clinical Investigation. vol. 107, No. 11. Jun. 2001.
Stamm, et al, “Autologous bone-marrow stem-cell transplantation for myocardial regeneration”, The Lancet, vol. 361, pp. 45-46. Jan. 2003.
Rafii, et al, “Contribution of marrow-derived progenitors to vascular and cardiac regeneration”, Cell & Development Biology, vol. 13, pp. 61-67. 2002.
Makino, et al, “Cardiomyocytes can be generated from marrow stromal cells in vitro”, Journal of Clinical Investigation, vol. 103, No. 5, pp. 697-705. Mar. 1999.
Kamihata, et al, “Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines”, Circulation, vol. 104, pp. 1046-1052. 2001.
Tomita, Shinji, et al, “Autologous Transplantation of Bone Marrow Cels Improves Damaged Heart Function” Circulation, V. 100, Suppl. 19, pp. II-247 to II-256, 1999.
Kobayashi, Masanobu, et al, “Mobilization mechanisms of hematopoietic stem cells into peripheral blood”, Igaku No Ayumi, v. 176, No. 9, pp. 558-560, 1996.
Hayashi, Shin-ichiro et al.;Potential Role of Hepatocyte Growth Factor, a Novel Angiogenic Growth Factor, in Peripheral Arterial Disease, Downregulation of HGF in response to Hypoxia in Vascular Cells; 1999, pp. II-301-II-308.
A. Ishida et al; “Autologous Peripheral Blood Mononuclear Cell Implantation for Patients with Peripheral Arterial Disease Improves Limb Ischemia”;Circ. J. 69: pp. 1260-1265, 2005.
P. Huang et al; “Autologous Transplantation of Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood Mononuclear Cells Improves Critical Limb Ischemia in Diabetes”;Diabetes Care, vol. 28, No. 9, pp. 2155-2160; 2005.
K. Gupta et al; “Angiogenesis: a curse or cure?” www.postgradmedj.com; 81: 236-242, 2005.
J. E. Markkanen et al; “Growth factor-induced therapeutic angiogenesis and arteriogenesis in the heart—gene therapy”;Cardiovascular Research; vol. 65; pp. 656-664, 2005.
F. Squadrito et al; “The effects of recombinant human granulocyte-colony stimulating factor on vascular dysfunction and splanchnic stimulating factor on vascular dysfunction and splanchnic ischaemia-reperfusion injury”;British Journal of Pharmacology, vol. 120, No. 2, pp. 333-339, 1997.
K. E. Sullivan et al; “Effects of Perioperative Granulocyte Colony-stimulating factor on Horses with Ascending Colonic Ischemia”;Veterinary Surgery; vol. 22, No. 5, pp. 343-350. 1993.
U. Frank et al; “Treatment ofStaphylococcus aureusCatheter-Related Infection and Infective Endocarditis with Granulocyte Colony-Stimulating Factor in the Experiment Rabbit Model”;Antimicrobial Agents and Chemotherapy, vol. 40, pp. 1308-1310, 1996.
John Parissis et al., Hematopoietic Colony Stimulating Factors in Cardiovascular and Pulmonary Remodeling: Promoters or Inhibitors, vol. 12, No. 21, pp. 2689-2699.
Fukuda Keiichi
Hisaka Yasuyo
Miyai Tatsuya
Tamura Masahiko
Belyavskyi Michail A
Browdy and Neimark , P.L.L.C.
Chugai Seiyaku Kabushiki Kaisha
Fukuda Keiichi
Hisaka Yasuyo
LandOfFree
Remedies for ischemic disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Remedies for ischemic disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Remedies for ischemic disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4083787